List of Tables
Table 1. Targeted-protein Degradation Therapeutics Market Trends
Table 2. Targeted-protein Degradation Therapeutics Market Drivers & Opportunity
Table 3. Targeted-protein Degradation Therapeutics Market Challenges
Table 4. Targeted-protein Degradation Therapeutics Market Restraints
Table 5. Global Targeted-protein Degradation Therapeutics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Targeted-protein Degradation Therapeutics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Targeted-protein Degradation Therapeutics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Targeted-protein Degradation Therapeutics Product Type
Table 9. Key Companies Time to Begin Mass Production of Targeted-protein Degradation Therapeutics
Table 10. Global Targeted-protein Degradation Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted-protein Degradation Therapeutics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Targeted-protein Degradation Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Targeted-protein Degradation Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Targeted-protein Degradation Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Targeted-protein Degradation Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Targeted-protein Degradation Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Targeted-protein Degradation Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Targeted-protein Degradation Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Targeted-protein Degradation Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Targeted-protein Degradation Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Targeted-protein Degradation Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Targeted-protein Degradation Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Targeted-protein Degradation Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Targeted-protein Degradation Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Targeted-protein Degradation Therapeutics Sales Value by Region (2019-2024) & (%)
Table 27. Global Targeted-protein Degradation Therapeutics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Targeted-protein Degradation Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Targeted-protein Degradation Therapeutics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Targeted-protein Degradation Therapeutics Sales Value, (2025-2030) & (US$ Million)
Table 31. Arvinas Basic Information List
Table 32. Arvinas Description and Business Overview
Table 33. Arvinas Targeted-protein Degradation Therapeutics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Targeted-protein Degradation Therapeutics Business of Arvinas (2019-2024)
Table 35. Arvinas Recent Developments
Table 36. Nurix Therapeutics Basic Information List
Table 37. Nurix Therapeutics Description and Business Overview
Table 38. Nurix Therapeutics Targeted-protein Degradation Therapeutics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Targeted-protein Degradation Therapeutics Business of Nurix Therapeutics (2019-2024)
Table 40. Nurix Therapeutics Recent Developments
Table 41. Kymera Therapeutics Basic Information List
Table 42. Kymera Therapeutics Description and Business Overview
Table 43. Kymera Therapeutics Targeted-protein Degradation Therapeutics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Targeted-protein Degradation Therapeutics Business of Kymera Therapeutics (2019-2024)
Table 45. Kymera Therapeutics Recent Developments
Table 46. C4 Therapeutics Basic Information List
Table 47. C4 Therapeutics Description and Business Overview
Table 48. C4 Therapeutics Targeted-protein Degradation Therapeutics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Targeted-protein Degradation Therapeutics Business of C4 Therapeutics (2019-2024)
Table 50. C4 Therapeutics Recent Developments
Table 51. Key Raw Materials Lists
Table 52. Raw Materials Key Suppliers Lists
Table 53. Targeted-protein Degradation Therapeutics Downstream Customers
Table 54. Targeted-protein Degradation Therapeutics Distributors List
Table 55. Research Programs/Design for This Report
Table 56. Key Data Information from Secondary Sources
Table 57. Key Data Information from Primary Sources
Table 58. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Targeted-protein Degradation Therapeutics Product Picture
Figure 2. Global Targeted-protein Degradation Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Targeted-protein Degradation Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 4. Targeted-protein Degradation Therapeutics Report Years Considered
Figure 5. Global Targeted-protein Degradation Therapeutics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Targeted-protein Degradation Therapeutics Revenue in 2023
Figure 7. Targeted-protein Degradation Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. ARV-110 Picture
Figure 9. ARV-471 Picture
Figure 10. Other Picture
Figure 11. Global Targeted-protein Degradation Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Targeted-protein Degradation Therapeutics Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Cancer
Figure 14. Product Picture of Neuroscience
Figure 15. Product Picture of Other
Figure 16. Global Targeted-protein Degradation Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Targeted-protein Degradation Therapeutics Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Targeted-protein Degradation Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Targeted-protein Degradation Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Targeted-protein Degradation Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Targeted-protein Degradation Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Targeted-protein Degradation Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Targeted-protein Degradation Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Targeted-protein Degradation Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Targeted-protein Degradation Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Targeted-protein Degradation Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Targeted-protein Degradation Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Targeted-protein Degradation Therapeutics Sales Value (%), (2019-2030)
Figure 29. United States Targeted-protein Degradation Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Targeted-protein Degradation Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Targeted-protein Degradation Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Targeted-protein Degradation Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Targeted-protein Degradation Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Targeted-protein Degradation Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 35. China Targeted-protein Degradation Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Targeted-protein Degradation Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 37. China Targeted-protein Degradation Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Targeted-protein Degradation Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Targeted-protein Degradation Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Targeted-protein Degradation Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Targeted-protein Degradation Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Targeted-protein Degradation Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Targeted-protein Degradation Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Targeted-protein Degradation Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Targeted-protein Degradation Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Targeted-protein Degradation Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 47. India Targeted-protein Degradation Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Targeted-protein Degradation Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 49. India Targeted-protein Degradation Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 50. Targeted-protein Degradation Therapeutics Industrial Chain
Figure 51. Targeted-protein Degradation Therapeutics Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
